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Abstract 
Objectives: To study the clinical impact of a very high coronary artery calcium score 
(CAC >1000) in patients with no known coronary artery disease (CAD) and normal 
single photon emission computed tomography (SPECT) myocardial perfusion 
imaging (MPI). The secondary aim was to evaluate whether triple vessel disease 
would support the notion of balanced ischemia as an underlying mechanism of false 
negative SPECT MPI in patients with very high CAC. 
Background: No clinical data exists on the clinical value of extensive CAC in 
patients with normal SPECT MPI. 
Methods: 50 patients with suspected CAD and normal stress/rest SPECT MPI and 
CAC >1000 prospectively underwent invasive coronary angiography as standard of 
reference. Coronary lesions with ≥50% luminal diameter narrowing on invasive 
coronary angiography were considered as significant stenosis. 
Results: The median total CAC was 1975 (range 1018-8046). In 37/50 (74%) patients 
coronary angiography revealed 1-vessel disease (VD) (n = 15), 2-VD (n = 10) or 3-VD 
(n = 12). Twenty-six revascularizations (percutaneous coronary intervention/ coronary 
artery bypass grafting) were performed in 7 (6/1), 7 (6/1) and 12 (7/5) patients with 1-
VD, 2-VD and 3-VD, respectively. 
Conclusions: In patients with normal SPECT MPI a CAC >1000 confers a high 
diagnostic added value for detecting CAD. This is not solely based on unmasking 
balanced ischemia due to epicardial 3-VD as it occurred predominately in patients with 
1-VD and 2-VD. 
 
Key Words: Coronary artery disease, Coronary calcium score, balanced ischemia, 
normal SPECT/MPI 
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Abbreviations 
CAD = coronary artery disease 
CAC = coronary artery calcium score 
CT = computed tomography 
ECG = electrocardiogram 
LVEF = left ventricular ejection fraction 
MPI = myocardial perfusion imaging 
PET= positron emission tomography 
SPECT = single photon emission computed tomography 
SSS = summed stress score 
TID = transient ischemic dilation 
VD = vessel disease 
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Introduction 
Nuclear myocardial perfusion imaging (MPI) with single photon emission computed 
tomography (SPECT) is a well-established non-invasive method for detecting 
ischemia and the prognostic evaluation of patients with known or suspected coronary 
artery disease (CAD). A large body of literature has provided good evidence that 
normal SPECT MPI scan has a very high negative predictive value for ischemic heart 
disease and cardiovascular events in a general population. Atherosclerosis as an 
early stage of coronary heart disease is frequently associated with coronary 
calcifications.1-4 Recently, the coronary calcium (CAC) score has emerged as a new 
technique with incremental prognostic value compared to conventional 
cardiovascular risk factors. High values of CAC are often an indicator of stenotic 
lesions and are associated with an increased risk of cardiovascular events.5-8 
Because of the large discrepancy between the anatomic extent of CAD and ischemia 
- since many stenoses do not result in abnormal perfusion - the combination of the 
morphological anatomic information from CAC with functional information obtained 
from MPI may provide complementary information for the clinician.9-13 Due to the 
widespread availability of multislice computed tomography (CT) scanners and 
particularly with the integration of the latter into hybrid SPECT/CT or positron 
emission tomography (PET)/CT devices where low dose non-contrast CT scan for 
attenuation correction can be used for calculating CAC the clinical experience with 
CAC is growing.8, 14 However, in a small but important subset of patients results from 
the two modalities have been conflicting, i.e. normal SPECT MPI despite very high 
CAC.15-17 In a recent pilot study a cut off value for CAC at 709 was identified for the 
prediction of angiographic CAD despite normal SPECT MPI findings, suggesting 
balanced ischemia in multivessel disease.8 Although these data support the notion 
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that CAC may offer incremental diagnostic information over SPECT data for 
identifying patients with significant CAD and negative MPI results, systematic data is 
lacking. 
Therefore, the aim of the present study was to prospectively identify the rate of 
obstructive CAD in patients with normal SPECT MPI and a CAC >1000. This cut off 
value was chosen as previously suggested16, 18 - although slightly higher than the 
value described above8 - in order to ensure a high specificity in detection of clinically 
relevant CAD in agreement with the position statement of the working group on 
Nuclear Cardiology and Cardiac CT of the European Society of Cardiology 
classifying a CAC >1000 as extensive.19 A secondary aim was to evaluate whether 3-
vessel disease (VD) would support the notion of balanced ischemia as an underlying 
mechanism of false negative SPECT MPI in the presence of CAC >1000. 
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Methods 
Study population 
The present study included 50 consecutive patients with a suspected but no known 
CAD normal gated-SPECT and a CAC >1000. A gated-SPECT result was considered 
as normal as follows: no visual perfusion defect, summed stress score (SSS) <3, a 
left ventricular ejection fraction (LVEF) at rest (female/male) >50/45%20 and regular 
heart rate. An invasive coronary angiography served as a standard of reference and 
was performed based on previous data indicating in patients with normal SPECT MPI 
and high CAC a high incidence of angiographic CAD8 and an adverse outcome.16-17 
Despite lack of ischemia in SPECT a further diagnostic evaluation is also supported 
by studies reporting that high CAC is associated with extremely elevated risk of 
cardiac hard events. Written informed consent was obtained from all patients. 
 
Gated SPECT myocardial perfusion imaging 
Gated SPECT data acquisition was performed on a dual-head detector camera 
(Infinia or Ventri, GE Healthcare, Milwaukee, WI, USA), with a 1-day pharmacologic 
stress/rest MPI protocol using a weight-adjusted dose of 300 to 400 MBq of 99mTc-
tetrofosmin for stress (adenosine at standard rate of 0.14 mg/kg/min over 6 minutes) 
and a 3 fold higher dose of 99mTc-tetrofosmin for rest image acquisition. SPECT data 
was analyzed by two experienced imaging cardiologists with regard to the presence 
of reversible and/or fixed perfusion defects on short-axis, horizontal and vertical long-
axis slices as well as on the polar maps with a commercially available quantitative 
gated and perfusion SPECT software package (Cedars QGS/QPS; Cedars-Sinai 
Medical Center) which also allowed assessment of LVEF. In addition MPIs were 
assessed semi-quantitatively by segmental visual interpretation. A scan was 
 8
considered as normal if the summed stress score was <3.21-22 The use of low isotope 
dose in the first part of the one day protocol precludes meaningful assessment of 
transient ischemic dilatation (TID). As no values of transient ischemic dilatation (TID) 
have been validated for low-dose ECG-gated acquisition 60 minutes after vasodilator 
stress, we only provided visual assessment of TID using a 0-3 visual score (0=none, 
1=equivocal, 2=definite but moderate, and 3=severe), with ≥2 being considered 
abnormal, as previously reported.23 
 
Coronary artery calcium score 
A low-dose, unenhanced CT for SPECT MPI attenuation correction was performed 
on a LightSpeed VCT XT 64-slice CT standalone scanner (GE Healthcare) with the 
following scanning parameters: prospective ECG-triggering, 2.5 mm slice thickness, 
120 kV tube voltage, 200 mAs per rotation tube current, and a large scan field-of-
view of 50 x 50 cm. Co-registration was accomplished by visual quality control of 
emission (SPECT) and transmission scans (CT) using a commercially available and 
well established tool intergraded in the QGS/QPS software as previously reported.24 
No beta blocker was administered, and the average heart rate during acquisition was 
62±5 bpm. From this scan Agatston scores were computed with commercially 
available software (Smartscore, GE Healthcare), as previously reported.24 
 
Coronary angiography 
Invasive coronary angiography through the femoral artery was performed on an 
Allura 9 and an Allura XPER FD 10/10 (Philips Medical Systems) catheterisation 
equipment in an experienced catheterisation laboratory of a teaching hospital 
(University Hospital Zurich) following a protocol, which consists of a biplane 
angiography of left coronary artery with two radiation exposures in four orientations 
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and of the right coronary artery with two exposures in two orientations, as is routinely 
performed in our cardiology department as previously reported.25 Additional views 
could be performed at the operator’s discretion if necessary.  
At angiography, coronary artery lesions were considered to be significant stenoses 
when there was ≥50% luminal diameter narrowing (figure 1). CAD was defined as the 
presence of at least one significant stenosis. Patients with left main stenosis were 
categorized as 2-VD. 
The decision of the operator to perform percutaneous coronary intervention (PCI) or 
recommend coronary artery bypass graft (CABG) surgery was prospectively 
recorded. Lesions severity in coronary angiograms was visually assessed by two 
experienced interventional cardiologists and in case of disagreement a consensus 
between both was reached. The operators based this decision on their clinical 
judgment integrating the visual angiography finding with all available clinical 
information. No further complementary functional parameters such as for example 
the recently promoted functional flow reserve26 were available.  
 
Radiation Dose 
Values for effective radiation dose of low dose CT were calculated by multiplying the 
dose length product (DLP) with a conversion factor (k = 0.014 mSv/mGy x cm) as 
previously described27 and adopted in large trials.28 For estimating the effective 
radiation dose from SPECT MPI, we used a conversion factor of 6.9 x 10-3 mSV/MBq.29 
 
Statistical analysis 
Quantitative intergroup comparisons were performed with the Wilcoxon test (two 
groups) or the Kruskal–Wallis test (more than two groups). Variables were expressed 
as mean±standard deviation or median and range and categorical variables as 
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frequencies and percentages. CAC distribution between the main epicardial vessels 
was compared with the Friedman test. A p-value of <0.05 was considered to be 
statistically significant. SPSS software (version 15.0, SPSS Inc.; Chicago Illinois) was 
used for statistical testing. 
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Results 
Study population 
The mean age of the study population was 67±9 years, 72% were male. The mean 
number of risk factors was 2.5±1.2 and most patients were classified as intermediate 
risk by Framingham risk score which averaged 15.7±7.3 (median 15.5, range 3-31). 
The characteristics of the study population are given in table 1. 
 
SPECT 
According to the inclusion criteria following the study design all MPI at stress and rest 
were normal. The mean values for the summed rest, stress, and difference scores 
were 0.3±0.4, 0.7±0.9, 0.5±0.5. Mean LVEF was 63.7±4.3% at rest, and 62.8±6.3% 
after Adenosine-stress (p=n.s.). There was no significant adenosine-induced ST 
segment depression. TID score was 0 in 49 patients and equivocal in 1 patient. 
 
Coronary angiography 
Thirty-seven (74%) of the 50 patients had a significant CAD. This included 15 
patients with 1-VD (30%), 10 patients with 2-VD (20%) and 12 patients with 3-VD 
(24%) (figure 2A). Thus, in the majority of patients (78%) with unmasked CAD the 
underlying disease was not 3-VD (figure 2B). Twenty-six of the 37 CAD patients 
(70%) underwent coronary revascularization, i.e. PCI (n = 19) or CABG (n = 7). 
Among 37 patients with CAD 28 patients revealed a stenosis ≥80%. While PCI was 
evenly distributed among 1-VD, 2-VD and 3-VD patients, CABG was predominately 
performed in those with 3-VD (table 2). Remarkably, in 6 of the 13 patients without 
angiographic CAD the absence of any luminal irregularities was reported from 
angiography, despite massive calcification. 
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Coronary artery calcium score 
The median CAC of the study population was 1975 (range 1018-8046), while the 
respective values for patients with and without CAD was 1930 (range 1026-8046) 
and 1977 (range 1018–3007). The median CAC in patients with 1-VD was 1476 
(range 1026-5009) and tended to be higher in 2-VD and 3-VD, i.e. 2289 (range 
1294–8046) and 2190 (range 1332–5915) although the difference fell short of 
statistical significance (p = 0.15) (figure 2). Median CAC was significantly lower in 
LMA (52, range 0–751) and RCA (279, range 0-2884) compared to LAD (686, range 
0–751) (p ≤0.001). 
 
Radiation dose from SPECT MPI and Coronary artery calcium score 
The average DLP for CAC measurement was 72.2±22.2 mGy x cm resulting in a 
dose estimation of 1.0±0.3 mSv. Estimated effective dose from SPECT MPI was 
8.5±1.2 mSv.29 
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Discussion 
The present data indicate that a CAC >1000 is a predictor of CAD in patients with 
intermediate pretest probability for CAD and normal SPECT MPI as angiographically 
significant lesion were found in 74% of the study population. The presence of 
atherosclerosis does not necessarily reflect obstructive coronary lesions and 
conversely coronary lesions do not necessarily confer hemodynamic relevance. 
However, an increasing CAC is generally associated with an increase in abnormal 
SPECT findings.10, 12-13 For example, Anand et al. observed a prevalence of silent 
ischemia in 18% of patients with a CAC of 100-400, while the prevalence increased 
to 45% in patients with CAC >400.30 It has been reported that a high CAC in patients 
with normal SPECT MPI reflects non obstructive atherosclerosis which should be 
recognized as a preclinical state with strong predictive value for the development of 
CAD5 and should therefore, encourage aggressive risk factor modification according 
to NCEP guidelines.31 
Our study extends these observations towards the upper end of the CAC spectrum. 
In patients with massive coronary calcifications these not only reflect an increased 
cardiovascular risk5, but more importantly extensive coronary calcifications with a 
CAC >1000 appear to unmask obstructive CAD undetected by SPECT MPI. Although 
the pooled literature reports an overall sensitivity of SPECT MPI to detect multivessel 
disease ranging from 80%-95%32-33, only in 29% of patients with 3-VD defects are 
found in all three territories.34 By its nature, SPECT allows only detection of relative 
perfusion defects. Therefore, the true extent of myocardial ischemia may be 
underestimated particularly in vascular territories adjacent to areas with more severe 
coronary stenosis. 
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Consequently, in cases with evenly distributed ischemia without inducible flow 
heterogeneity among the different vessel territories balanced ischemia has been 
hypothesized to explain lack of perfusion defects. This however, is unlikely to be a 
main contributing factor to the results of the present study because a 3-VD was found 
in less than a third of the CAD patients. The concept of balanced ischemia may not 
be solely based on balanced epicardial coronary lesion severity, but rather could also 
be caused by microcirculatory dysfunction35-36 where global hyperemic myocardial 
flow response and myocardial flow reserve are blunted.31 A massive increase in CAC 
would then - although measured in the epicardial vessel - reflect involvement of the 
coronary microcirculatory tree, potentially associated with a decrease in myocardial 
flow reserve favoring a balanced hyperemic response due to blunted flow 
heterogeneity. This is in line with a recent study documenting that a high CAC is 
paralleled by endothelial dysfunction.37 There is increasing evidence that even non-
obstructive CAD with coronary calcification may impair hyperemic flow increases as 
determined with PET or MRI.39-41 Concordantly, Pirich et al. have reported that 
relevant coronary calcification can be confined to one epicardial coronary vessel, 
while myocardial flow reserve is reduced in all vascular territories, therefore not 
revealing any perfusion abnormality by visual image analysis.38 This was further 
substantiated by the fact that flow response was significantly lower in patients with 
CAC >100 compared to those with CAC <100, although overall no correlation 
between CAC and flow reserve was found. This, however, may have been due to the 
study design including only patients with relatively low CAC (median 142, range 0–
915), where the vascular reactivity is not yet strongly affected. By contrast our study 
population with a median CAC of 1974 (range 1018-8046) represents a more 
advanced stadium of CAD and atherosclerosis in which microcirculatory involvement 
is very likely to be present even in myocardial segments subtended by non-stenotic 
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coronary arteries as previously reported.42 This may provide the ground for balanced 
ischemia on the microcirculatory level of the coronary tree in patients with extensive 
coronary calcifications without 3-VD. This is further supported by a previous study 
reporting obstructive lesions in 12% of territories with normal SPECT MPI but 
massive calcifications.43 
Study limitations: It may be perceived as a limitation of the present study, that the 
classification of coronary lesions as significant was not complemented by a functional 
assessment such as fractional flow reserve. The latter was not yet implemented into 
our daily routine during our study which was completed before the solid data from 
Tonino et al.26 became available and before FFR has been adopted in the latest ESC 
guidelines for revascularization.44 Therefore, the standard of reference was solely 
based on visual evaluation of luminal narrowing. This, however, reflects common 
daily practice in many coronary catheterization laboratories45 and is in line with recent 
randomized trials evaluating coronary revascularization, like the COURAGE (Clinical 
Outcomes Utilizing Revascularization and Aggressive Drug Evaluation), BARI 2D 
(Bypass Angioplasty Revascularization Investigation 2 Diabetes), and SYNTAX 
(Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac 
Surgery) studies, in which lesions with diameter stenosis ≥50% based on visual 
estimation of the angiogram were generally considered for revascularization.46-48 
An additional limitation may be the fact that our definition of normal MPI was mainly 
based on normal findings of perfusion and rest LVEF as our protocol with scanning 
late after adenosine stress does not allow to benefit from the incremental diagnostic49 
and prognostic23 value of TID or stress induced wall motion abnormalities to identify 
CAD. However, the prevalence of CAC >1000 in normal SPECT MPI approximates 
7% at our institution comparing favorably to the reported range of 9-11%.10, 16-17 This 
underlines the validity of our method to classify a SPECT scan as normal, because 
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classifying scans inappropriately as normal would result in a higher incidence of CAC 
>1000.  
Furthermore, the present study was focused on the prevalence of epicardial coronary 
lesions in patients with normal myocardial perfusion and the diagnostic value of 
extensive coronary calcification to unmask CAD. Therefore, the study was not 
powered and not designed to provide outcome data. 
Finally, whether adjustment of the cut-off value for CAC would be appropriate in 
different patient populations with different pre-test likelihood must remain a matter of 
discussion as our data do not allow commenting on this. 
Conclusions: In intermediate risk patients with normal MPI a CAC >1000 confers an 
incremental diagnostic value for detecting CAD. This is not solely based on 
unmasking balanced ischemia due to epicardial 3-VD as it occurred predominantly in 
patients with 1-VD and 2-VD. Therefore, further evaluation of CAD with invasive 
coronary angiography including FFR and / or initiation of aggressive optimal medical 
therapy should be considered in these patients. 
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Figure 1: Patient with a normal perfusion SPECT MPI on polar map (stress: upper 
panel; rest: lower panel) (A) and extensive calcifications in the calcium scoring scan 
of the left descending artery (LAD), left circumflex artery (LCX) and right coronary 
artery (RCA) with a total Agatston score of 1555 (B). The corresponding coronary 
angiography revealed multivessel disease with most severe lesions in the RCA 
(black arrows) and a total distal occlusion (white arrow) (C). 
 
Figure 2: Distribution of patients (n = 50) with normal SPECT MPI and very high 
CAC >1000, stratified by the number of angiographically diseased vessels (0-, 1-, 2-, 
3-VD). 
 
Figure 3: Relationship between the number of diseased coronary vessels (0-, 1-, 2-, 
3-VD) and calcium score (Agatston score). The circles demonstrate outliers. The 
Kruskal-Wallis p-value for a difference of calcium scores between the groups 
amounts to 0.15 (n.s.). 
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LBBB = left bundle branch block
Table 1  Baseline characteristics (n = 50) 
Male     36 (72%) 
Age (y)  
Mean ± SD     67±9 
Range     51-87 
Framingham risk score     15±7.3 
Hypertension     42 (84%) 
Dyslipidemia     24 (48%) 
Diabetes      16 (32%) 
Smoking      23 (46%) 
Obesitiy (>30 kg/m²)     11 (22%) 
Reasons for referral  
Typical angina     14 (28%) 
Atypical chest pain       6 (12%) 
New onset of LBBB       1 (2%) 
Syncope       1 (2%) 
Preoperative evaluation     19 (38%) 
Dyspnea       5 (10%) 
Positive exercise test       4 (8%) 
 26
 
 
 
 
 
 
 
 
 
 
 
 
CAD = coronary artery disease 
VD = vessel disease 
PCI = percutaneous coronary intervention 
CABG = coronary artery bypass grafting 
Table 2  Angiographic CAD and revascularization 
Angiographic CAD Patients PCI CABG 
0-VD 13 0 0 
1-VD 15 6 1 
2-VD 10 6 1 
3-VD 12 7 5 
total 50 19 7 
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